INTRODUCTION
Cholangiolocellular carcinoma, a rare type of primary malignant tumor of liver, is thought to originate from cholangioles or canals of Hering, where hepatic progenitor or stem cells are located, 1, 2 and has characteristic histologic features of tubular, cord-like and 'antler-like' pattern with marked fibrous stroma. 3 Cholangiolocellular carcinoma was previously classified as one type of intrahepatic cholangiocarcinoma. But now, on the basis of the concept that combined hepatocellular-cholangiocarcinoma is derived from hepatic progenitor cells, cholangiolocellular carcinoma is classified as combined hepatocellular-cholangiocarcinoma with stem-cell features in the latest version of the World Health Organization (WHO) classification of the digestive system 2010. 3 Because of its limited number of cases, its biologic behavior or clinical outcomes have not been fully understood.
CASE SUMMARY
A 62-year-old male presented with abdominal pain and dyspnea. He was a chronic alcoholic and had no positive markers for hepatitis virus. On physical examination, he showed epigastric tenderness. Initial serum aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase levels were 48 IU/L, 19 IU/L and 167 IU/L, respectively. Serum alpha-fetoprotein, carcinoembryonic antigen and carbohydrate antigen 19-9 levels were 4.9 ng/mL, 2.2 ng/mL and 12.1 U/mL, respectively. Abdominal computed tomography and magnetic resonance imaging showed a 5 cm-sized peripheral enhancing lesion with centripetal enhancement pattern, and multiple arterial enhancing nodules in right hepatic lobe. Under the impression of intrahepatic malignant tumor, he underwent a right lobectomy of liver.
PATHOLOGICAL FINDINGS
On gross examination, liver surface showed multiple protruding nodules. On serial section of the liver, there was a 5 cm-sized whitish firm and fibrotic mass and more than 10 multiple small satellite nodules with same consistency and color of the largest mass ( Fig. 1) . Microscopically, the 5 cm-sized largest mass showed tumor cells arranged in tubular, cord-like and anastomosing histologic pattern, so called "antler-like" pattern with mild nuclear atypia in the marked fibrous stroma of which the typical findings of cholangiolocellular carcinoma (Fig. 2) . Most of other satellite nodules showed same histologic findings. But, there were two satellite nodules which revealed different histologic findings from other nodules. Tumor cells of these nodules had more abundant cytoplasm than other nodules, showed trabecular or cluster like structural pattern rather than tubular or antler-like pattern, and had scant intervening fibrous stroma. These histologic findings were intermediate differentiation between hepatocellular carcinoma and cholangiocarcinoma. On immunohistochemical stainings, the cells of typical cholangiolocellular carcinoma nodules were positive for keratin 19, but the tumor cells showing intermediate differentiation were negative for keratin 19. Both type cells were negative for hepatocyte paraffin 1 (HepPar-1) which is relatively specific marker for hepatocellular carcinomas and positive for epithelial cell adhesion molecule (EpCAM) which is used as stem/ progenitor cell marker (Fig. 3) . Through these findings, the diagnosis of combined hepatocellular-cholangiocarcinoma with stemcell features, cholangiolocellular type could be made.
DISCUSSION
Combined hepatocellular-cholangiocarcinoma, a rare primary malignant liver tumor, is composed of unequivocal, intimately mixed components of both hepatocellular carcinoma and cholangiocarcinoma. 3 Classical type of combined hepatocellular-cholan- This case showed multiple masses with mainly typical histologic 1,2 However, its clinical outcome has not been clarified because of its limited number of cases. There are some reports not only that cholangiolocellular carcinoma has poor outcome as much as intrahepatic cholangiocarcinoma but also that cholangiolocellular carcinoma has favorable long-term survival. 6, 7 There are two studies for clinicopathological analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. 8, 9 But these studies also had limited number of cases (less than 100 patients). So it is required more cases and studies for evaluation of prognosis and treatment strategy in cholangiolocellular carcinoma patients.
